•
Dec 31, 2022
Y-mAbs Q4 2022 Earnings Report
Y-mAbs reported increased DANYELZA net revenues and progress in pipeline development.
Key Takeaways
Y-mAbs reported a net revenue increase of 228% compared to Q4 2021, driven by DANYELZA sales and license revenue. The company also implemented a restructuring plan and anticipates a reduction in annual operating expenses for 2023.
Reported record DANYELZA net revenues of $16.4 million in Q4 2022, a 31% sequential increase.
DANYELZA was conditionally approved in China, with a planned launch in the first half of 2023.
Implemented a restructuring plan with a 35% reduction in force and an anticipated 28% reduction in annual operating expenses for 2023.
Cash and cash equivalents totaled $105.8 million as of December 31, 2022, expected to support business operations into Q1 2026.
Y-mAbs
Y-mAbs
Forward Guidance
Management reiterated its 2023 financial guidance.